Sulfite Alters the Mitochondrial Network in Molybdenum Cofactor Deficiency.
Autor: | Mellis AT; Department of Chemistry, Institute for Biochemistry, University of Cologne, Cologne, Germany., Roeper J; Department of Chemistry, Institute for Biochemistry, University of Cologne, Cologne, Germany., Misko AL; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States., Kohl J; Department of Chemistry, Institute for Biochemistry, University of Cologne, Cologne, Germany., Schwarz G; Department of Chemistry, Institute for Biochemistry, University of Cologne, Cologne, Germany.; Center for Molecular Medicine, University of Cologne, Cologne, Germany. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in genetics [Front Genet] 2021 Jan 07; Vol. 11, pp. 594828. Date of Electronic Publication: 2021 Jan 07 (Print Publication: 2020). |
DOI: | 10.3389/fgene.2020.594828 |
Abstrakt: | Molybdenum cofactor deficiency (MoCD) is an autosomal recessive disorder belonging to the large family of inborn errors in metabolism. Patients typically present with encephalopathy and seizures early after birth and develop severe neurodegeneration within the first few weeks of life. The main pathomechanism underlying MoCD is the loss of function of sulfite oxidase (SO), a molybdenum cofactor (Moco) dependent enzyme located in mitochondrial intermembrane space. SO catalyzes the oxidation of sulfite (SO Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2021 Mellis, Roeper, Misko, Kohl and Schwarz.) |
Databáze: | MEDLINE |
Externí odkaz: |